Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors.
about
Heart Failure: Diagnosis, Management and UtilizationNeoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosidesNormal targeting of a tagged Kv1.5 channel acutely transfected into fresh adult cardiac myocytes by a biolistic methodA single direct injection into the left ventricular wall of an adeno-associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction.Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications.Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution.Endothelium-dependent coronary vasodilatation requires NADPH oxidase-derived reactive oxygen species.In vivo acceleration of heart relaxation performance by parvalbumin gene deliveryModified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarctionHeart failure management: the present and the future.Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene reduces the vasoconstrictive response.Cardiac gene therapy: optimization of gene delivery techniques in vivo.Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters.Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo.Gene therapy for vein grafts.Vectors for gene therapy of cardiovascular disease.Myocardial gene transfer.Sustained expression of vascular endothelial growth factor and angiopoietin-1 improves blood-spinal cord barrier integrity and functional recovery after spinal cord injuryXIAP gene expression protects β-cells and human islets from apoptotic cell deathCardiac gene therapyGenetic manipulation of beta-adrenergic signalling in heart failure.Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure.Targeting calcium cycling proteins in heart failure through gene transfer.Oxidative stress and heart disease: cardiac dysfunction, nutrition, and gene therapy.Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heartMyocardial regeneration: present and future trends.The evolution of heart gene delivery vectorsGene delivery approaches to heart failure treatment.Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).Gene therapy for the extension of vein graft patency: a review.Overview of recent advances in molecular cardiology.Creation of a cardiotropic adeno-associated virus: the story of viral directed evolution.Gene therapy for the prevention of vein graft diseaseProgress in gene therapy of dystrophic heart disease.Gene therapy for cardiac arrhythmias: a dream soon to come true?Hepatocyte growth factor/Met gene transfer in cardiac stem cells--potential for cardiac repair.Current strategies for myocardial gene delivery.Gene therapy in heart failure.Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart.
P2860
Q26745543-AD744B5F-F178-47EE-A7C8-951AC96EA555Q28364092-325B3B22-F99E-4E08-8F97-E2AC05833C94Q28576468-81608FC0-7D86-42B4-B04A-D18EC279FB02Q30413864-73DBA3AD-C4AB-4093-95A1-F5275AB0921BQ30427066-1C0C0C11-AFB1-4CB0-A88C-58227D2FC8B6Q30431585-D42D0176-9CB8-4D09-BA36-62044BE45F4BQ30496168-542004B0-193A-489C-BB50-78F7FDE727DAQ30501538-9C5457E3-18C8-4337-83DA-C252B0DCE9B6Q30580723-51060E1D-D0E9-49FC-99B7-2D8279597085Q33605156-6923E358-A316-4DD8-A81E-A7CF3E7CB2E5Q33807737-2A8B7491-5A8E-4613-BA2C-41CA289D16A4Q33832137-C1384F7E-BEFA-4D38-98CC-BAD2515DF803Q33894636-00A13B4A-2C33-4468-A5AF-C6C24BABFF31Q33919915-C144A5C1-97D8-4E8E-94B7-24FF5F02AF96Q34027380-86D5DCD7-CEDC-4550-AD87-09557319A27FQ34027386-AF1CEFA1-767F-4FF8-9D4E-E22FC93374C9Q34119456-8F5B15EE-FE24-4A83-8E44-1EB1B2EA1FC0Q34296847-D06EF710-0F4D-4A86-81DA-5CAC0710199EQ34380509-49DBC2F5-DB3E-48BB-AF54-4E78144DDFE8Q34409721-AE9C4A5A-355D-48F9-BBDB-301673A1682DQ34419016-1EFBC4C5-CB80-4CD4-AEDB-142B721F1BB2Q34482530-89712BE7-A4E7-4571-A46C-54B976F27AD8Q34978011-5E79891F-BA6E-42BB-908E-55B868FCEF30Q35037546-76E95D8C-E65F-4E90-B589-84FE56E639F7Q35118301-61D6B489-3F26-4443-86AF-608ABF40E3D5Q35576360-A1358130-34D4-4EF5-81E5-92CC14809402Q35631316-FD8FC5D7-B2CF-4527-87CD-DF8373A0050CQ35799722-6308B78A-0562-47AC-AC88-D1B16E8266B5Q35873759-F2FD86AA-B839-4918-8532-D7D2622F5A16Q35904461-19EA41BD-1DCA-4F90-9F0C-77A83EFBD3C8Q36032833-3B9D9B22-B5B5-4FC1-A4AA-EF0DBB0CD90FQ36415354-49943EA9-C246-46DE-B6BA-3C1D590803A7Q36614445-53CD6BEC-F416-4DA1-BBFB-AC6EA287A86FQ36698258-EBD1C008-DA93-45AA-9BB3-E0E26AA64F1AQ36773242-82074D10-3B07-460E-8B1C-765888A2A235Q36800517-8F71A80B-96E6-4B1B-B066-7BC088B025CBQ36840751-E506CD81-D1EE-4D67-B041-60C44DA1B4E4Q36931967-A33C36E0-0F43-4EC0-821C-1BB27AF0254EQ36944623-6D4454E2-8B8D-4C99-991F-D6E5B567AE8CQ36968864-14BE7273-30EA-4D70-BA2F-7AC4E419550A
P2860
Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Efficient and stable transduct ...... deno-associated virus vectors.
@en
Efficient and stable transduct ...... deno-associated virus vectors.
@nl
type
label
Efficient and stable transduct ...... deno-associated virus vectors.
@en
Efficient and stable transduct ...... deno-associated virus vectors.
@nl
prefLabel
Efficient and stable transduct ...... deno-associated virus vectors.
@en
Efficient and stable transduct ...... deno-associated virus vectors.
@nl
P2093
P356
P1433
P1476
Efficient and stable transduct ...... deno-associated virus vectors.
@en
P2093
Marshall DJ
Svensson EC
P304
P356
10.1161/01.CIR.99.2.201
P407
P577
1999-01-01T00:00:00Z